Tvaster Genkalp
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection.
$1.25M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 9, 2021 (5 years old)
About Tvaster Genkalp
Our approach transforms diagnostics into smarter, patient-centric molecular testing.
Funding rounds
- Series A · $1.25MSource: fundraisingfox.com
- Website created
Companies like Tvaster Genkalp
OOncoliqSeed · Jul 2026DDxcover$6.2M Series A · Feb 2025
EElypta$21M · Jun 2022
PPrima MenteSeed · Apr 2026
OOncoReviveCCopilot IQSeries A · Oct 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tvaster-genkalp (get a free API key).